Oncgnostics

Germany
Kleinniedesheim, Rheinland-Pfalz, Germany
49 3641 933544 ★

Company profile

Oncgnostics company profile

oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer diagnostics. The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These marker regions are detected using well-established PCR-based technologies, which can be performed in routine molecular diagnostics laboratories with standard equipment. oncgnostics has identified novel markers for detecting cervical precancerous lesions and carcinomas.

Business identity

Contact email
[email protected]
Phone number
49 3641 933544
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2012-02-01

Headquarters

Headquarters
Kleinniedesheim, Rheinland-Pfalz, Germany
Postal code
07745
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Last funding
Corporate Round / 2023-09-05
Last equity funding
Corporate Round
Investors
6
Lead investors
1
Founders
5
Articles
1

Founders and investors

Founders

Alfred HanselKerstin BroxMartina SchmitzMatthias DurstPeter Haug

Lead investors

Grande Bio-tech

Investors

bm-t beteiligungsmanagement thuringenHTGF (High-Tech Gruenderfonds)ITAI GmbHSparkasse JenaSTIFT Thueringen

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.